Compare Corticosteroid

15 products »

close Created with Sketch.

Maxidex

Alcon, a Novartis Division

Maxidex (dexamethasone ophthalmic suspension) 0.1% is an adrenocortical steroid indicated for steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies.

At-a-Glance
  • Mechanism of Action: Dexamethasone suppresses the inflammatory response to a variety of agents and it probably delays or slows healing.
  • Dosage: One or two drops topically in the conjunctival sac(s). In severe disease, drops may be used hourly, being tapered to discontinuation as the inflammation subsides. In mild disease, drops may be used up to four to six times daily.

Details

FDA

Yes

CE Mark

Not specified

Active Ingredients

Dexamethasone

Application

Topical

Status

Prescription

Strength

0.1%

Company Information

Contact the company for additional information, availability, or pricing:

Alcon, a Novartis Division

alcon.com

6201 South Freeway

Fort Worth, TX 76134